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health-related quality of life in AHSCT patients. The Symptom
Distress Scale (SDS) was used to identify 11 treatment-related
symptoms and the associated degree of distress. Patients’ rated
each symptom on days 30 and 100 following AHSCT with 1
indicating no awareness of a change from normal to 5, the highest
degree of discomfort. Symptom perception was a rating of a symp-
tom as  2 on the SDS; symptom evaluation was a rating of the
associated symptom distress as 2 (mild), 3 (moderate), or 4 -5
(severe). Symptoms were identiﬁed as forming groups when 3 or
more symptoms existed concurrently. Data were analyzed using
descriptive statistics and Pearson’s product-moment correlations.
Results: At day 30, patients (N67) were mostly male (69%), with
ECOG performance status 0 or 1 (82%) and a mean age of 40 years
(SD 13). Patients (n57) at day 100 were mostly male (63%),
with ECOG 0 or 1 (51%) and a mean age of 38 years (SD11). At
day 30, patients reported fatigue (90%) and appetite (79%) as the
most prevalent symptoms with appetite as the most distressing
(22%). At day 100, the most prevalent symptoms were fatigue
(81%) and appearance (60%) with fatigue as the most distressing
(11%). Several groups of co-existing symptoms were identiﬁed.
The largest group (fatigue, appetite, insomnia, bowel pattern) was
identiﬁed in 30 (45%) patients at day 30 with a signiﬁcant (p0.01)
correlation (r.50) between appetite and bowel pattern. A smaller,
prevalent group (fatigue, bowel pattern, insomnia) was identiﬁed in
17 (30%) patients at day 100 with signiﬁcant (p0.05) correlations
between: insomnia and fatigue (r.50); and insomnia and bowel
patterns (r.50). Conclusion: At a time of transitioning from
hospital discharge to the home community, patients perceive mul-
tiple symptoms with appetite (day 30) and fatigue (day 100) as
severely distressing. Symptoms coexist concurrently to form sev-
eral groups and within the larger groups, few relationships exist
between symptoms.
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FLY ME TO THE MOON
Caraher, R.3, Ahmed, S.3, Frey, M.A.3, Jordan, L.E.3, Kurtzberg, J.3
1Duke University Hospital, Durham, NC; 2The Duke Pediatric Blood
and Marrow Transplant Family Support Program, Durham, NC; 3The
Duke Pediatric Blood and Marrow Transplant Program, Durham, NC.
The care of the pediatric patient undergoing blood and marrow
transplantation is complex and intense. Patients undergoing this
type of treatment are often critically ill and many will succumb to
their treatment or disease. Patients are often hospitalized for
months and parents/caregivers are required to stay with them for
the duration of the hospitalization. The stress and burden on both
the caregiver and the nursing staff is immense. Numerous studies
have now focused on caregiver burnout and compassion fatigue of
staff caring for these children. Burnout and turnover rates of staff
are often much higher than the National average. The Duke
Pediatric Blood and Marrow Program has developed several pro-
grams to support caregivers and staff working in this environment.
The team adheres to a primary nursing model. The primary nurs-
ing team provides continuity and consistency for both the child and
family. Additional components for our support program include a
Family Support Program and a highly trained social worker staff.
The purpose of this abstract is to present the Duke Pediatric Blood
and Marrow “Fly Me To The Moon Program”. This program was
developed to supplement existing programs that support the emo-
tional and psychosocial needs of the patient and nursing staff. The
program incorporates basic principles including bereavement ac-
tivities, nursing retention strategies and caregiver support. The
goals of the program are to reduce caregiver stress and burnout and
to support nurses caring for these patients. The presentation will be
introduced with a slide show and music, speciﬁc tools and activities
used in the program will then be discussed.
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NURSING INITIATIVES TO ADDRESS ETHICAL DILEMMAS ON A BLOOD
AND MARROW TRANSPLANT (BMT) UNIT
Causton, C.A.1, Johnston, P.A.1, Neumann, J.L.1, Slieper, C.1 1MD
Anderson Cancer Center, Houston, TX.
Ethical issues and questions are a consistent aspect of caring for
Blood & Marrow Transplant (BMT) patients. The complexity of
the treatment and potential side effects are ongoing challenges.
The advancement of BMT speciﬁc treatments with new and cut-
ting edge protocols that expand our patient selection criteria, while
exciting and challenging, present nursing staff with constant ethical
questions.
On our BMT unit, monthly Nursing Ethics rounds are pre-
sented. Both night shift and day shift participate in rounds that
include the Institutional Clinical Ethicist, and BMT Program Di-
rector, a registered nurse who functions also as an adjunct ethicist
throughout the institution. A discussion topic is assigned each
month. An associated article is forwarded to all staff prior to rounds
to read as background. This is an educational opportunity for the
nursing staff to increase their knowledge of ethical principles and
dilemmas as well as an opportunity to discuss their concerns about
individual patients.
Another avenue for nursing staff to address ethical issues is
through monthly long term multidisciplinary rounds that focus on
BMT patients with extended length of stays. The multidisciplinary
group consists of the Clinical Ethicist, social worker, chaplain,
physical and occupational therapy, case management and nursing.
The bedside nurse presents the individual patient to the group.
Patients for discussion are chosen by established criteria and all
aspects of their progress and care are discussed. Many issues are
raised with resolution strategies addressed with the medical team.
Frequently in this venue, ethical concerns are discussed as the
broad picture is presented.
Both of these initiatives are venues organized by nurses and
provide the opportunity to discuss ethical issues of concern in
caring for a complex patient population as well as to establish
realistic future goals.
Multiple resources are used to select patients for discussion at
long term multidisciplinary rounds. To illustrate the methodology
used, a case study will be presented indicating the patient care
problems, concerns and suggestions by the multidisciplinary group
with patient outcomes. A list of topics discussed at monthly Nurs-
ing Ethics rounds will be presented showing the educational con-
tent that is presented to nursing staff.
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PROPHYLACTIC USE OF HIGH CONCENTRATION FLUORIDE RINSE IN
THE HEMATOPOIETIC CELL TRANSPLANT PATIENT: PROMISING PO-
TENTIAL FOR DECREASING ORAL MUCOSITIS
East, K.A.1,2, Oholendt, M.S.1,2, Kamble, R.1,3, Carrum, G.1,3,
Bross, A.2 1Center for Cell and Gene Therapy, Houston, TX; 2The
Methodist Hospital, Houston, TX; 3Baylor College of Medicine, Houston,
TX.
Transplant nursing brings with it a host of patient issues includ-
ing but not limited to clinical, social, emotional, and ﬁnancial. As
transplant nurses it is our responsibility to provide our patients
with the best care available. One of the most impacting complica-
tions in the hematopoietic cell transplant (HCT) patient is oral
mucositis. Oral mucositis brings with it signiﬁcant effects on the
patient’s clinical course such as pain, anorexia, dysguesia, insomnia,
and infection.
Background/Purpose: Our department’s standard for oral care
in the HCT patient included a 0.4% ﬂuoride toothpaste (Gel-
KamTM) and 0.9% saline mouth rinse every 2 hours while awake.
Beginning in November of 2005 we initiated the use of a high
concentration ﬂuoride rinse (MEDOralTM) daily in addition to our
standard regimen. We noticed over a period of months a decrease
in the severity of oral mucositis. Retrospectively, we looked at
twenty-ﬁve (14 autologous and 11 allogeneic) patients to evaluate
the addition of MEDOralTM. Patients conditioning regimens var-
ied and included agents known to increase risk of mucositis. A
preliminary evaluation showed twelve of the twenty-ﬁve patients
had evidence of oral mucositis, grade I-II. Though there appears to
be a decrease in the severity/frequency of oral mucositis in these
patients, all twelve required some type of patient controlled anal-
gesia for grade III-IV esophagitis. These ﬁndings indicate that the
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addition of the high concentration ﬂuoride rinse may beneﬁt HCT
patients and potentially decrease the severity and frequency of oral
mucositis. Plan:We plan to conduct a prospective study on the use
of high concentration ﬂuoride rinse in the HCT patients.
Conditioning Regimens (n)
Autologous (14) Allogeneic(11)
HD Melphalan (7) Bu/Flu/Cam (1)
BEAM-R (6) Flu/Mel/Cam (2)
BEAM (1) Cy/TBI/Cam (3)
Bu/Flu/MTX (1)
Cy/TBI/MTX (2)
Bu/Cy/MTX (1)
Mel/TBI (1)
Abbreviations: HD-high dose; BEAM- carmustine, etoposide, cyt-
arabine, melphalan; R-Rituximab; Bu-busulfan; Flu-ﬂudara-
bine; Cam- Alemtuzumab; Mel- melphalan; Cy- cyclophosph-
amide; TBI- total body irradiation; MTX- methotrexate.
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MAKING THE LEAP: SUCCESSFUL INTEGRATION OF A PEDIATRIC BONE
MARROW TRANSPLANT POPULATION WITHIN AN EXISTING ADULT
BONE MARROW TRANSPLANT UNIT
Eron, B.1, Marlow, C.1, Coghill, A.1, Talbert, G.1, Shea, T.1 1Univer-
sity of North Carolina Health Care System, Chapel Hill, NC.
The University of North Carolina Health Care System’s Adult
Bone Marrow and Stem Cell Transplant Program was estab-
lished in 1992. Since that time over 900 transplants have been
performed. In 2004 UNC Health Care System made a commit-
ment to expand the scope of the BMT Program and develop a
pediatric transplant unit. The pediatric hematology/oncology
physicians accurately predicted the need to offer marrow and
stem cell transplants to the children of North Carolina and
surrounding areas. Pediatric patients and their families ex-
pressed a desire to receive comprehensive care at one facility.
Physicians recognized that the successful recruitment of top
pediatric hematologists/oncologists was dependent upon an ac-
credited transplant program. The adult unit at UNC was iden-
tiﬁed as the site for a combined adult-pediatric BMT unit.
Several areas were identiﬁed as pivotal for success. Goals were
established to facilitate the transition. Senior staff, in coopera-
tion with nurse educators, prepared existing staff by providing a
calm, comfortable and safe environment for learning the skills
vital to successful pediatric nursing. A pediatric BMT core
curriculum was developed and updated as protocols and prac-
tices changed. Physicians presented in-services speciﬁc to pedi-
atric diseases. Pediatric nurse educators were available when
questions surfaced about nursing practice and equipment. The
UNCH oncology nursing residency program expanded to in-
corporate adult and pediatric practice. A BMT nurse joined the
pediatric nursing practice group to expand the unit’s knowledge
of pediatric issues. The unit chaplain initiated meetings with
nurses to discuss emotional challenges related to pediatric ill-
ness and death. Psychosocial meetings and family conferences
changed to increase nursing participation. This established a
connection between families and staff prior to admission.
The purpose of this poster is to describe the steps necessary for
successful integration of a pediatric population within an existing
adult bone marrow transplant unit including:
 Insuring that the adult BMT nursing staff felt supported during
this transition
 Educating to insure that clinical skills set and competencies are
adequate
 Providing emotional and spiritual support for staff dealing for
the ﬁrst time with issues surrounding morbidity and mortality in a
pediatric population.
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A BMT-BASED DIABETIC TEACHING PROGRAM: RESPONDING TO THE
NEEDS OF ALLOGENEIC PATIENTS WITH STEROID-INDUCED HYPER-
GLYCEMIA
Estepa-Estrella, J.M.A.1, Johnston, P.1, dela Cruz, B.1,
Austria-Granada, M.L.R.1, Ascuna, J.1 1UT MD Anderson Cancer
Center, Houston, TX.
Allogeneic patients are faced with multi-faceted needs through-
out the transplant process. More than 50% develop graft versus
host disease (GVHD) and are started on high dose steroid therapy
as the frontline treatment. Consequently, due to high dose steroid
therapy, patients develop steroid induced hyperglycemia which is
further aggravated by onset of infections or sepsis. Steroid induced
hyperglycemia poses signiﬁcant risks to allogeneic patients as the
condition persists simultaneously with steroid therapy wherein
dosing depends greatly on severity of symptoms of GVHD. As a
result, patients are faced with challenges that include recovery of
counts, prevention of infection, and managing the ill effects of
steroid induced hyperglycemia.
Patient education is an important role played by nurses in pro-
viding quality patient care. Through an individualized teaching
program, patients are equipped with the essential knowledge and
skills that help them go through the rigors of recuperation. Dia-
betic teaching is imperative for patients and their caregivers to
assist them in coping with the demands of hyperglycemia. Teach-
ings include monitoring and recording blood sugar levels, safe and
effective use of insulin, recognizing and managing acute compli-
cations, diet modiﬁcation and other self-care measures. Since the
BMT patient cannot leave the home unit to attend class held twice
a week by the diabetic educator, individual teaching at earliest
available time needs to be arranged. This frequently results in
delays (beyond institutional guidelines) on the day of discharge.
In response, the discharge nurses were tasked to incorporate
diabetic teaching prior to the patient’s discharge. The outline of
the program was modiﬁed to meet the speciﬁc needs of allogeneic
patients. Signiﬁcantly, patients and caregivers have expressed bet-
ter understanding of the condition and conﬁdence in carrying out
the skills required. Follow-up with the outpatient team is conﬁrm-
ing these outcomes. The diabetic teaching program and education
tool utilized will be presented.
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A CULTURE OF SAFETY: PROMOTING A SAFE ENVIRONMENT ON THE
DUKE PEDIATRIC BLOOD AND MARROW TRANSPLANT UNIT
Frey, M.A.2, Hutchinson, B.2 1Duke University Hospital, Durham, NC;
2The Duke Pediatric Blood and Marrow Transplant Program, Durham,
NC.
Six years ago the, Institute of Medicine (IOM) issued its land-
mark report on medical errors, To Err Is Human: Building a Safer
Health System. The reports ﬁnding indicated that as many as 98,00
people die each year due to medical errors (Leape and Berwick
2005). Many organizations have reviewed this report and have
initiated programs to promote safety. None have take the charge
more seriously than The Duke Pediatric Blood and Marrow
Transplant Unit. This unit is categorized as an intensive care unit.
The unit administers extremely high volumes of medications,
blood products and other supportive therapies. The length of stay
is long and the patients are very tenuous. The purpose of this
poster is to decribe the Duke Pediatric Blood and Marrow Trans-
plant Program Safety Program. This program is aligned with the
JCAHO 2007 National Safety Goals. The objectives of the pro-
gram are to minimize errors, promote safety at all times and instill
a just culture of safety among our staff. The program is led and
strongly supported by physician leaders. It is multidisciplinary in
nature and focuses on all aspects of safety within the inpatient unit.
Major initiatives and accomplishments will be presented.
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“RECOVERY”: DEVELOPMENT OF A BMT DISCHARGE TEACHING PAM-
PHLET
Garavgalia, K.1 1Barnes-Jewish Hospital/Siteman Cancer Center, St.
Louis, MO.
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